Analyst Price Targets — ITRI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 18, 2026 12:40 pm | — | Oppenheimer | $133.00 | $96.43 | TheFly | Itron price target raised to $133 from $125 at Oppenheimer |
| February 18, 2026 9:54 am | — | Robert W. Baird | $128.00 | $96.43 | TheFly | Itron upgraded to Outperform from Neutral at Baird |
| February 13, 2026 1:26 pm | Joseph Osha | Guggenheim | $155.00 | $94.70 | TheFly | Itron downgraded to Neutral at Guggenheim after estimates lowered |
| January 27, 2026 12:41 pm | Noah Kaye | Oppenheimer | $125.00 | $98.38 | TheFly | Itron price target lowered to $125 from $145 at Oppenheimer |
| January 5, 2026 3:27 pm | — | Johnson Rice | $130.00 | $96.91 | TheFly | Itron upgraded to Buy from Accumulate at Johnson Rice |
| November 25, 2025 3:19 pm | — | Seaport Global | $138.00 | $97.78 | TheFly | Itron price target lowered to $138 from $140 at Seaport Research |
| October 31, 2025 2:00 pm | Scott Graham | Seaport Global | $140.00 | $100.35 | TheFly | Itron price target lowered to $140 from $155 at Seaport Research |
| October 31, 2025 11:44 am | Noah Kaye | Oppenheimer | $145.00 | $104.02 | TheFly | Itron price target lowered to $145 from $155 at Oppenheimer |
| October 31, 2025 9:00 am | — | Robert W. Baird | $118.00 | $108.99 | TheFly | Itron downgraded to Neutral from Outperform at Baird |
| August 4, 2025 10:54 am | — | Stephens | $130.00 | $125.75 | TheFly | Itron price target raised to $130 from $110 at Stephens |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for ITRI

Coherent is expected to continue to benefit from a transition to products that enable faster throughput speeds, while prior constraints on manufacturing capacity appear to be alleviating. BrightSpring Health Services reported another strong quarter with both revenues and EBITDA up significantly, far outpacing its historical growth rate prior to going public in 2024. Varonis Systems, which provides data protection…
Itron, Inc. (NASDAQ: ITRI - Get Free Report) SVP Laurie Ann Pulatie-Hahn sold 3,755 shares of the stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $99.54, for a total transaction of $373,772.70. Following the completion of the sale, the senior vice president directly owned 33,679
Itron, Inc. (NASDAQ: ITRI - Get Free Report) SVP Donald Reeves III sold 1,071 shares of the business's stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $100.17, for a total transaction of $107,282.07. Following the completion of the sale, the senior vice president directly owned
Itron, Inc. (NASDAQ: ITRI - Get Free Report) SVP John Marcolini sold 1,074 shares of the business's stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $100.17, for a total transaction of $107,582.58. Following the completion of the transaction, the senior vice president owned 25,838 shares of the
Itron, Inc. (NASDAQ: ITRI - Get Free Report) SVP Justin Patrick sold 828 shares of Itron stock in a transaction on Friday, February 20th. The shares were sold at an average price of $100.17, for a total value of $82,940.76. Following the sale, the senior vice president directly owned 33,516 shares of the company's stock, valued
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ITRI.
U.S. House Trading
No House trades found for ITRI.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
